Company Filing History:
2 out of 1,976 
1 out of 78 Years Active: 2013-2019
Title: Angela Coxon: Innovator in Cancer Treatment
Introduction
Angela Coxon is a prominent inventor based in Moorpark, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on the development of therapeutic methods that utilize specific biomarkers and inhibitors.
Latest Patents
Angela's latest patents include groundbreaking inventions related to cancer treatment. One patent discusses the use of biomarkers and MET inhibitors for the therapeutic treatment of cancer. This invention outlines methods for selecting patients based on cancer biomarkers, such as MET amplification and high MET expression. Another patent describes specific binding agents that interact with hepatocyte growth factor (HGF). This invention includes methods for treating cancer by administering a pharmaceutically effective amount of these specific binding agents to HGF, as well as methods for detecting the amount of HGF in a sample.
Career Highlights
Throughout her career, Angela has worked with notable companies in the biotechnology sector, including Amgen Inc. and Amgen Fremont Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment.
Collaborations
Angela has collaborated with several professionals in her field, including Teresa Lynn Burgess and Larry L. Green. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Angela Coxon is a dedicated inventor whose work in cancer treatment has the potential to significantly impact patient care. Her innovative patents and collaborations highlight her commitment to advancing medical science.